Sujal Patel has been here before. He weathered the 2009 recession as CEO of Isilon Systems, coming out the other end to sell his company the next year for $2.25… Read More
Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of Washington shot is ready for rollout in South Korea, and… Read More
Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Sana Biotechnology will build a cell therapy manufacturing facility in Woodinville, Washington, nixing… Read More
It was a week of accolades, partnerships and new programs in the Pacific Northwest life sciences scene. University of Washington geneticist Evan Eichler landed on Time magazine’s list of “100… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
Cell therapy company Century Therapeutics will receive a $100 million up front payment and $50 million in equity investment from Bristol Myers Squibb in a deal announced Monday. Under the… Read More
Pharmaceutical giant Bristol Myers Squibb has been quietly growing in the Seattle area. Since acquiring Celgene and its Seattle operations two years ago, BMS now has more than 1,240 employees… Read More